TABLE 1.

Baseline characteristics of 62 participants with Fanconi anemia^a

Characteristic	Value
Age (mean ± SD) (yr)b	16.8 ± 8.9
Age at blood draw (n = 62)
<18 yr	37 (59.7)
≥18 yr	25 (40.3)
Gender (n = 62)
Female	35 (56.4)
Male	27 (43.6)
Individual who completed the survey (n = 62)
Self	32 (51.6)
Mother	23 (37.1)
Father	6 (9.7)
Grandmother	1 (1.6)
Race (n = 62)b
American Indian/Alaskan Native	2 (3.2)
Asian	0 (0.0)
Black/African American	3 (4.8)
Native Hawaiian/Pacific Islander	0 (0.0)
White	57 (91.9)
Other	2 (3.2)
Ethnicity (n = 56)c
Hispanic/Latino	7 (12.5)
Not Hispanic/Latino	47 (83.9)
Do not know	2 (3.6)
Marital status (≥18 yr only) (n = 25)
Unmarried	20 (80.0)
Married	4 (16.0)
Not asked	1 (4.0)
Ever had genital or anal warts (n = 54)d
No	51 (94.4)
Yes	3 (5.6)
Ever had common warts (n = 50)e
No	32 (64.0)
Yes	11 (22.0)
Not asked	7 (14.0)
Ever had HPV vaccine (n = 56)f
No	32 (57.1)
Yes	24 (42.9)
FA complementation group (n = 61)g
FancA	24 (39.3)
FancB	0 (0.0)
FancC	6 (9.8)
Other	10 (16.4)
Do not know	21 (34.4)
Ever had a bone marrow transplant (n = 58)h
No	28 (48.3)
Yes	30 (51.7)
Ever had a sexual experience with another person (n = 59)i
No	39 (66.1)
Yes	20 (33.9)

^aValues are reported as no. (%) unless indicated otherwise.

^bTwo participants selected two categories (American Indian/Alaska Native and white).

^cSix observations were excluded because of missing ethnicity data.

^dEight observations were excluded because serum was collected >30 days after survey completion and the participant reported no history of genital or anal warts.

^eOne observation was excluded because serum was collected >30 days after survey completion and the participant reported no history of common warts; 3 observations were excluded because serum was collected >30 days prior to survey completion and the participant reported a history of common warts. Eight observations were also excluded because of missing common wart data.

^fThree observations were excluded because serum was collected >30 days prior to survey completion and the participant reported having had an HPV vaccine and the year of the last shot administered was not prior to the year of serum collection; 3 observations were excluded because serum was collected more than 30 days after survey completion and the participant reported having not had an HPV vaccine.

^gOne observation was excluded because of missing FA complementation group data.

^hFour observations were excluded because serum was collected more than 30 days after survey completion and the participant reported no history of bone marrow transplant.

ⁱOne observation was excluded because serum was collected >30 days after survey completion and the participant reported no sexual experience; one observation was excluded because serum was collected >30 days prior to survey completion and the participant reported a history of sexual experience but the minimum age of any sexual activity was missing. One observation was also excluded because of missing sexual activity data.